Inflammatory Bowel & Immunobiology Research Institute Team

Nine components of a large, multidisciplinary force of more than 120 individuals dedicated to improving the lives of people with IBD.

The experts at the Inflammatory Bowel and Immunobiology Research Institute (IBIRI) work to fulfill our "bench to bedside" approach to care. By rapidly integrating new discoveries into patient treatment plans, these dedicated professionals helped Cedars-Sinai become an international leader in gastroenterology and gastrointestinal surgery.

Stephan R. Targan, MD
Feintech Family Chair in Inflammatory Bowel Disease, Director, Inflammatory Bowel Disease Center, Director, F. Widjaja Foundation Inflammatory Bowel and Immunobiology Research Institute
Faculty
Janine Bilsborough, PhD
Director, Drug Discovery and Development
Jonathan Braun, MD, PhD
Director, IBD Enterprise Operations
Nirupama Bonthala, PhD
Suzanne Devkota, PhD
Edward Feldman, MD
Director, IBD Psychosocial Program
Phillip Fleshner, MD
Director, IBD Surgery Research
Christina Ha, MD
Director, IBD Advanced IBD Fellowship Program
Dermot P. McGovern, MD, PhD
Director of IBD Translational Medicine
Gil Y. Melmed, MD
Director, IBD Clinical Research, Co-director, IBD Clinical Operations
Kathrin Michelsen, PhD
Shervin Rabizadeh, MD
Director, IBD Clinical Operations and Pediatric IBD Research
David M. Underhill, PhD
Director, IBD Basic Science Research
Eric Vasiliauskas, MD
Director, Nutrition & Integrative IBD
Andrea Wolf, PhD
Have Questions or Need Help?

Contact us if you have questions or wish to learn more about the IBIRI.

Inflammatory Bowel & Immunobiology Research Institute
8700 Beverly Blvd.
Davis Building, Suite D4063
Los Angeles CA 90048